Safety and clinical outcomes of antithrombotic therapy in children and young adults with kidney failure on dialysis: a 10-year single-center retr…
@aspneph.bsky.social
@aspneph.bsky.socialSafety and clinical outcomes of antithrombotic therapy in children and young adults with kidney failure on dialysis: a 10-year single-center retr…
@aspneph.bsky.socialThe relationship between plasminogen activator inhibitor-1 levels and blood pressure in adolescents with a history of prematurity and/or low birt…
@ispdcongress.bsky.social🎥 Hear why #ISPD2026 is the place to be!
Join the global PD community in Cape Town, 2–6 October 2026, for learning, connection and collaboration.
Watch the video and register today! 🌍
@aspneph.bsky.socialMycophenolate mofetil versus tacrolimus for maintenance of remission in children with frequently relapsing and steroid-dependent nephrotic syndro…
@theisn.orgISN members get more from kidney science. 📖
This weekend’s @kidneyint.bsky.social #ISNFridaySelection explores new genetic loci for kidney function.
Read ➡️ https://bit.ly/4cvpEHW
Join/renew ➡️ https://bit.ly/4w8LacX
@sodatroubles.bsky.socialPathological Diagnostic Criteria for Thrombotic Microangiopathy in the Renal Allograft: Lessons Learned During the Banff Working Group Consensus Process
#nephsky #nephrology
www.kidneymedicinejournal.org/article/S259...
@aspneph.bsky.socialBirth characteristics and growth outcome in children with nephropathic cystinosis compared with other chronic kidney disease entities prior to ki…
@aspneph.bsky.socialPrimary Mitochondrial-Disorders-Associated Nephropathy in Adulthood. [Review]
@uwnephrology.bsky.socialOur 2nd-yr UW #nephrology fellows joined the Origins of Renal Physiology course in Bar Harbor, ME, at the Mt. Desert Island Biological Labs! Studying in a collaborative & immersive environment w/ peers & mentors from across the country, & having loads of FUN! #MedEd #kidney @uwmedicine.bsky.social
@aspneph.bsky.socialHospitalization Costs of Kidney Transplantation Associated With Induction Therapy Among Pediatric Kidney Transplant Recipients: A North American Pediatric Renal Trials and Collaborative Studies and Pediatric Health Information System Collabo…
@aspneph.bsky.socialQuantum Dot–Based Fluorescent Lateral Flow... : Journal of the American Society of Nephrology
@ukkidney.org🩺 Work in primary care?
💬 Join the conversation & share your perspective to help shape a community-informed Kidney Disease Strategy.
💻 Primary care virtual listening event: 15 Sept | 12:30
🔗 Register now: https://ow.ly/t5Y250ZLfMu
@runningkidneys.bsky.socialAre we thinking about immunosuppression-related ♋️ risk the right way?
In glomerular disease, “net immunosuppression” may matter more than any single 💊—integrating cumulative exposure, kidney function, viral status, age & disease factors.
@ispdcongress.bsky.social🌍 Did you know #ISPD26 will feature an African Nephrology Forum?
Join experts and colleagues to share knowledge, strengthen collaboration and advance kidney care across Africa.
📅 29 Sep–3 Oct | Cape Town
👉 ispd2026.org
#ISPD26 #ISPDCongress #PeritonealDialysis #RenalCare #Nephrology
@sodatroubles.bsky.socialAcute glucagon infusion induces natriuresis and diuresis through a direct tubular mechanism involving overlapping receptor pathways
#nephsky #nephrology
journals.physiology.org/doi/full/10....
@tenuretracker.bsky.socialUniversity of Washington is hiring:
Assistant, Associate, or Professor of Clinical Practice, Nephrology
@uwnephrology.bsky.social✨🤩UW Nephrology services begin today on the NW Campus! Dr. Rajnish Mehrotra, head of #Nephrology, says this opens possibilities unavailable elsewhere. “Leading-edge innovation and science, clinical trials - that is the opportunity we offer.” @uwmedicine.bsky.social #Seattle #Kidneycare
@runningkidneys.bsky.social💉 GLP-1 receptor agonists may offer benefits in hemodialysis.
In a cohort of 4,984 patients, their use was associated with 9% fewer hospitalizations and 17% lower mortality.
Observational findings that require confirmation.
@genesndiseases.bsky.socialCan disease-causing proteins be eliminated, not just blocked?
This review highlights #PROTAC technology as a promising strategy to target kidney disease drivers and advance precision therapies in #nephrology.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
@aspneph.bsky.socialCystinosis-associated metabolic bone disease: pathogenesis and outcome [Review]
